FDA's Third-Party Review Program

Medtech Matters by Medical Product Outsourcing

May 14, 202661:00Health

In this Medtech Matters podcast episode of Mike on Medtech with Mike Drues, president of Vascular Sciences, we’re discussing the FDA’s third-party review program. This option is available for certain 510k reviews. It is...

Related Episodes

Continue listening to more episodes from Medtech Matters.

ECRI's 2026 Top 10 Health Technology Hazards

Jul 30, 2026 - 57:26

In this Medtech Matters podcast episode of Mike on Medtech with Mike Drues, president of Vascular Science...

Measuring Regulatory/Quality Team Member Performance

Jun 3, 2026 - 62:20

In this Medtech Matters podcast episode of Mike on Medtech with Mike Drues, president of Vascular Science...

Triaging Your QMS: Considerations Based on the New QMSR

Apr 17, 2026 - 59:19

In this Medtech Matters podcast episode of Mike on Medtech with Mike Drues, president of Vascular Science...

A Deep Dive into E&L and Biocomp Testing

Mar 11, 2026 - 22:09

In this Medtech Matters podcast episode, sponsored by Nelson Labs , we’re discussing the importance of E&...

Planning for FDA Shutdowns Now and in the Future

Oct 27, 2025 - 57:28

In this Medtech Matters podcast episode of Mike on Medtech with Mike Drues, president of Vascular Science...

Should Wellness Products Come with a Warning?

Sep 11, 2025 - 66:02

In this Medtech Matters podcast episode of Mike on Medtech with Mike Drues, president of Vascular Science...

3 Most Common Premarket (Postmarket?) Review Issues FDA Sees

Jun 25, 2025 - 53:16

In this Medtech Matters podcast episode of Mike on Medtech with Mike Drues, president of Vascular Science...

Why Are One-Third of MAUDE Reports a Problem?

Jun 10, 2025 - 58:10

In this Medtech Matters podcast episode of Mike on Medtech with Mike Drues, president of Vascular Science...